Copyright
©The Author(s) 2016.
World J Gastroenterol. Sep 7, 2016; 22(33): 7604-7612
Published online Sep 7, 2016. doi: 10.3748/wjg.v22.i33.7604
Published online Sep 7, 2016. doi: 10.3748/wjg.v22.i33.7604
Plasma, n | DBS, n | Sensitivity (%) | Specificity (%) (95%CI) | ROC | PPV | NPV | |||||
Negative | Positive | Negative | Positive | (95%CI) | |||||||
Anti-HCV | 288 | 116 | 292 | 112 | 96.6 | (91.4; 99.1) | 100.0 | (98.7; 100) | 0.98 | 100.0% | 98.6% |
HBsAg | 318 | 86 | 319 | 85 | 96.5 | (90.1; 99.3) | 99.4 | (97.7; 99.9) | 0.98 | 97.6% | 99.1% |
Anti-HBc | 232 | 172 | 286 | 118 | 68.0 | (60.5; 74.9) | 99.6 | (97.6; 100) | 0.84 | 99.2% | 80.8% |
Anti-HBs | 246 | 158 | 337 | 67 | 42.4 | (34.6; 50.5) | 100.0 | (98.5; 100) | 0.71 | 100.0% | 73.0% |
Anti-HIV | 289 | 115 | 290 | 114 | 98.3 | (93.9; 99.8) | 99.7 | (98.1; 100) | 0.99 | 99.1% | 99.3% |
- Citation: Mössner BK, Staugaard B, Jensen J, Lillevang ST, Christensen PB, Holm DK. Dried blood spots, valid screening for viral hepatitis and human immunodeficiency virus in real-life. World J Gastroenterol 2016; 22(33): 7604-7612
- URL: https://www.wjgnet.com/1007-9327/full/v22/i33/7604.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i33.7604